Consequences of OX40-OX40 ligand interactions in Langerhans cell function: Enhanced contact hypersensitivity responses in OX40L-transgenic mice

European Journal of Immunology

Volumn 32, Issue 11, 2002, Pages 3326-3335

  Sato, Takayuki ^a   Ishii, Naoto ^a   Kikuchi, Kazu ^a   Nakagawa, Satoshi ^a   Ndhlovu, Lishomwa C ^a   Sugamura, Kazuo ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Antigen presenting cell; Contact hypersensitivity; Langerhans cell; OX40 ligand

Indexed keywords

ALLOANTIGEN; CD134 ANTIGEN; CD4 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HAPTEN; LIGAND;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; EAR; EDEMA; FEMALE; HYPERSENSITIVITY; LANGERHANS CELL; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SENSITIZATION; TRANSGENE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD27; ANTIGENS, CD80; DERMATITIS, CONTACT; LANGERHANS CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 0036857838     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200211)32:11<3326::AID-IMMU3326>3.0.CO;2-9     Document Type: Review

References (43)

1. Janeway, C. A. Jr. and Bottomly, K., Signals and signs for lymphocyte responses. Cell 1994. 76: 275-285.
2. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
3. Coyle, A. J. and Gutierrez-Ramos, J. C., The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2001. 2: 203-209.
4. Chambers, C. A., The expanding world of co-stimulation: the two-signal model revisited. TRENDS. Immunol. 2001. 22: 217-223.
5. Gramaglia, I., Weinberg, A. D., Lemon, M. and Croft, M., OX40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 1998. 161: 6510-6517.
6. Akiba, H., Oshima, H., Takeda, K., Atsuta, M., Nakano, H., Nakajima, A., Nohara, C., Yagita, H. and Okumura, K., CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 1999. 162: 7058-7066.
7. Hurtado, J. C., Kim, S.H., Pollok, K. E., Lee, Z. H. and Kwon, B. S., Potential role of 4-1BB in T cell activation: comparison with the costimulatory molecule CD28. J. Immunol. 1995. 155: 3360-3367.
8. Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G. L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., Spear, P. G. and Ware, C. F., LIGHT, a new member of the TNF superfamily, and lymphotoxin are ligands for herpesvirus entry mediator. Immunity 1998. 8: 21-30.
9. Miura, S., Ohtani, K., Numata, N., Niki, M., Ohbo, K., Ina, Y., Gojobori, T. and Sugamura, K., Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T cell leukemia virus type I transactivator p40tax. Mol. Cell. Biol. 1991. 11: 1313-1325.
10. Murata, K., Ishii, N., Takano, H., Miura, S., Ndhlovu, L. C., Nose, M., Noda, T. and Sugamura, K., Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 2000. 191: 365-374.
11. Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewiski, C. and Delespesse, G., Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 1997. 159: 3838-3848.
12. Brocker, T., Gulbranson-Judge, A., Flynn, S., Riedinger, M., Raykundalia, C. and Lane, P., CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 1999. 29: 1610-1616.
13. Weinberg, A. D., Wegmann, K. W., Funatake, C. and Whitham, R. H., Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 1999. 162: 1818-1826.
14. Ndhlovu, L. C., Ishii, N., Murata, K., Sato, T. and Sugamura, K., Critical involvement of OX40 ligand signals in the t cell priming events during experimental autoimmune encephalomyelitis. J. Immunol. 2001. 167: 2991-2999.
15. Gramaglia, I., Jember, A., Pippig, S. D., Weinberg, A. D., Killeen, N. and Croft, M., The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 2000. 165: 3043-3050.
16. Kopf, M., Ruedl, C., Schmitz, N., Gallimore, A., Lefrang, K., Ecabert, B., Odermatt, B. and Bachmann, M. F., OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 1999. 11: 699-708.
17. Chen, A. I., McAdam, A. J., Buhlmann, J. E., Scott, S., Lupher, M. L., Jr., Greenfield, E. A., Baum, P. R., Fanslow, W. C., Calderhead, D. M., Freeman, G. J. and Sharpe, A. H., OX40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999. 11: 689-698.
18. Maxwell, J. R., Weinberg, A., Prell, R. A. and Vella, A. T., Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 2000. 164: 107-12.
19. Rogers, P. R., Song, J., Gramaglia, I., Killeen, N. and Croft, M., OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001. 15: 445-455.
20. Bansal-Pakala, P., Jember, A. G. and Croft, M., Signaling through OX40 (CD134) breaks peripheral T cell tolerance. Nat. Med. 2001. 7: 907-12.
21. Higgins, L., McDonald, S. A. C., Whittle, N., Crockett, N., Shields, J. G. and MacDonald, T. T., Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel diseases with OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 1999. 162: 486-493.
22. Malmström, V., Shipton, D., Singh, B., Al-Shamkhani, A., Puklavec, M. J., Barclay, A. N. and Powrie, F., CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitiss in T cell- restored SCID mice. J. Immunol. 2001. 166: 6972-6981.
23. Jember, A. G., Zuberi, R., Liu, F. T. and Croft, M., Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J. Exp. Med. 2001. 193: 387-392.
24. Macatonia, S. E., Knight, S. C., Edwards, A. J., Griffiths, S. and Fryer, P., Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluoresence in isothiocyanate. Functional and morphological studies. J. Exp. Med. 1987. 166: 1654-1667.
25. Kripke, M. L., Munn, C. G., Jeevan, A., Tang, J. M. and Bucana, C., Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 1990. 145: 2833-2838.
26. Grabbe, S. and Schwarz, T., Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 1998. 19: 37-44.
27. Sligh, J. E., Jr., Ballantyne, C. M., Rich, S. S., Hawkins, H. K., Smith, C. W., Bradley, A. and Beaudet, A. L., Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 1993. 90: 8529-8533.
28. Rauschmayr-Kopp, T, Williams, I. R., Borriello, F., Sharpe, A. H. and Kupper, T. S., Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen. Eur. J. Immunol. 1998. 28: 4221-4227.
29. Moodycliffe, A. M., Shreedhar, V., Ullrich, S. E., Walterscheid, J., Bucana, C., Kripke, M. L. and Flores-Romo, L., CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J. Exp. Med. 2000. 191: 2011-2020.
30. Rudikoff, D. and Lebwohi, M., Atopic dermatitis. Lancet 1998. 351: 1715-1721.
31. Ohki, O., Yokozeki, H., Katayama, I., Umeda, T., Azuma, A., Okumura, K. and Nishioka, K., Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br. J. Dermatol. 1997. 136: 838-845.
32. Macatonia, S. E., Edwards, A. J. and Knight, S. C., Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 1986. 59: 509-514.
33. Paterson, D. J., Jefferies, W. A., Green, J. R., Brandon, M. R., Corthesy, P., Puklavec, M. and Williams, A. F., Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 1987. 24: 1281-1290.
34. Mallett, S., Fossum, S. and Barclay, A. N., Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes, a molecule related to nerve growth factor receptor. EMBO J. 1990. 9: 1063-1068.
35. Calderhead, D. M., Buhlmann, J. E., Eetwegh, A. J. Van der, Claasen, E., Noelle, R. J. and Fell, H. P., Cloning of mouse OX40: a T cell activation marker that may mediate T-B interactions. J. Immunol. 1993. 151: 5261-5271.
36. Baum, P.R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R. and Clifford, K. N., Molecular characterization of murine and human OX-40/OX-40 ligand systems: identificationof a human OX-40 ligand as the HTLV-1 -regulated protein gp34. EMBO J. 1994. 13: 3992-4001.
37. Takasawa, N., Ishii, N., Higashimura, N., Murata, K., Tanaka, Y., Nakamura, M., Sasaki, T. and Sugamura, K., Expression of gp34 (OX40 ligand) and OX40 on human T cell clones. Jpn. J. Cancer Res. 2001. 92: 377-382.
38. Baba, E., Takahashi, Y., Lichtenfeld, J., Tanaka, R., Yoshida, A., Sugamura, K., Yamamoto, N. and Tanaka, Y., Functional CD4 T cells after intercellular molecular transfer OX40 ligand. J. Immunol. 2001. 167: 875-883.
39. + T cells. Immunol. Rev. 1998. 165: 231-247.
40. Anderson, D. E., Sharpe, A. H. and Hafler, D. A., The B7-CD28/CTLA-4 costimulatory pathways in autoimmune diseases of the central nervous system. Curr. Opin. Immunol. 1999. 11: 677-683.
41. Xu, H. Guan, H., Bullard, G., Hanson, J., Slater, M. and Elmets, C. A., The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 2001. 31: 3085-3093.
42. Niwa, H., Yamamura, K. and Miyazaki, J., Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991. 108: 193-199.
43. Murata, K. Nose, M., Ndhlovu, L, C., Sato, T., Sugumura, K. and Ishii, N. A., Constitutive OX40/OX40 ligand interaction induces autoimmune-like disease. J. Immunol. 2002. 169: in press.